Atlas Trials

A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)

Clinical trial NCT07680907 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07680907
Sponsor
Janssen-Cilag Farmaceutica Ltda.
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2026-09-30
Primary completion
2026-11-30
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.